The discovery of a link between stromal COMP and adverse clinical outcomes motivated us to investigate how stromal COMP in the TME influences ovarian cancer cells, which might provide crucial insights into the mechanisms underlying ovarian cancer progression and metastasis. Here, COMP is linked to ovarian cancer.